Gadolinium-Functionalized Peptide Amphiphile Micelles for Multimodal Imaging of Atherosclerotic Lesions

ACS Omega

Volumn 1, Issue 5, 2016, Pages 996-1003

  Yoo, Sang Pil ^a   Pineda, Federico ^b   Barrett, John C ^a   Poon, Christopher ^b   Tirrell, Matthew ^a   Chung, Eun Ji ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85021117539     PISSN: None     EISSN: 24701343     Source Type: Journal    
DOI: 10.1021/acsomega.6b00210     Document Type: Article

References (43)

1. Mozaffarian, D.; Benjamin, E. J.; Go, A. S.; Arnett, D. K.; Blaha, M. J.; Cushman, M.; de Ferranti, S.; Després, J.-P.; Fullerton, H. J.; Howard, V. J.; Huffman, M. D.; Judd, S. E.; Kissela, B. M.; Lackland, D. T.; Lichtman, J. H.; Lisabeth, L. D.; Liu, S.; Mackey, R. H.; Matchar, D. B.; McGuire, D. K.; Mohler, E. R.; Moy, C. S.; Muntner, P.; Mussolino, M. E.; Nasir, K.; Neumar, R. W.; Nichol, G.; Palaniappan, L.; Pandey, D. K.; Reeves, M. J.; Rodriguez, C. J.; Sorlie, P. D.; Stein, J.; Towfighi, A.; Turan, T. N.; Virani, S. S.; Willey, J. Z.; Woo, D.; Yeh, R. W.; Turner, M. B. Heart Disease and Stroke Statistics-2015 Update: A Report From the American Heart Association Circulation 2015, 131 e29 10.1161/CIR.0000000000000152
2. NHLBI. What is atherosclerosis? http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis (accessed Oct 30, 2015).
3. Staff, M. C. Arteriosclerosis/atherosclerosis. http://www.mayoclinic.org/diseases-conditions/arteriosclerosis-atherosclerosis/diagnosis-treatment/research/rsc-20167164 (accessed Oct 30, 2015).
4. American Heart Association. What is Cardiovascular Disease?, 2016. http://www.heart.org/HEARTORG/Caregiver/Resources/WhatisCardiovascularDisease/What-is-Cardiovascular-Disease-UCM-301852-Article.jsp#.V-XWT9orI2w.
5. Otsuka, F.; Nakano, M.; Kolodgie, F. D.; Virmani, R., Evaluation of Vulnerable Atherosclerotic Plaques. In Coronary Artery Disease; Willerson, T. J.; Holmes, J. R. D., Eds.; Springer: London, 2015; pp 409-419.
6. Briley-Saebo, K. C.; Mulder, W. J. M.; Mani, V.; Hyafil, F.; Amirbekian, V.; Aguinaldo, J. G. S.; Fisher, E. A.; Fayad, Z. A. Magnetic resonance imaging of vulnerable atherosclerotic plaques: Current imaging strategies and molecular imaging probes J. Magn. Reson. Imaging 2007, 26, 460-479 10.1002/jmri.20989
7. Chung, E. J.; Tirrell, M. Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis Adv. Healthcare Mater. 2015, 4, 2408-2422 10.1002/adhm.201500126
8. Hartgerink, J. D.; Beniash, E.; Stupp, S. I. Self-assembly and mineralization of peptide-amphiphile nanofibers Science 2001, 294, 1684-1688 10.1126/science.1063187
9. Akerman, M. E.; Chan, W. C. W.; Laakkonen, P.; Bhatia, S. N.; Ruoslahti, E. Nanocrystal targeting in vivo Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 12617-12621 10.1073/pnas.152463399
10. Chung, E. J. Targeting and therapeutic peptides in nanomedicine for atherosclerosis Exp. Biol. Med. 2016, 241, 891-898 10.1177/1535370216640940
11. Peters, D.; Kastantin, M.; Kotamraju, V. R.; Karmali, P. P.; Gujraty, K.; Tirrell, M.; Ruoslahti, E. Targeting atherosclerosis by using modular, multifunctional micelles Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 9815-9819 10.1073/pnas.0903369106
12. Chung, E. J.; Mlinar, L. B.; Sugimoto, M. J.; Nord, K.; Roman, B. B.; Tirrell, M. In vivo biodistribution and clearance of peptide amphiphile micelles Nanomedicine 2015, 11, 479-487 10.1016/j.nano.2014.08.006
13. Kuo, C.-H.; Leon, L.; Chung, E. J.; Huang, R.-T.; Sontag, T. J.; Reardon, C. A.; Getz, G. S.; Tirrell, M.; Fang, Y. Inhibition of atherosclerosis-promoting microRNAs via targeted polyelectrolyte complex micelles J. Mater. Chem. B 2014, 2, 8142-8153 10.1039/C4TB00977K
14. Chung, E. J.; Pineda, F.; Nord, K.; Karczmar, G.; Lee, S.-K.; Tirrell, M. Fibrin-targeting, peptide amphiphile micelles as contrast agents for molecular MRI J. Cell Sci. Ther. 2014, 5, 181 10.4172/2157-7013.1000181
15. Mallat, Z.; Tedgui, A. Current Perspective on the Role of Apoptosis in Atherothrombotic Disease Circ. Res. 2001, 88, 998-1003 10.1161/hh1001.090571
16. Cui, H.; Webber, M. J.; Stupp, S. I. Self-Assembly of Peptide Amphiphiles: From Molecules to Nanostructures to Biomaterials Biopolymers 2010, 94, 1-18 10.1002/bip.21328
17. Trent, A.; Marullo, R.; Lin, B.; Black, M.; Tirrell, M. Structural properties of soluble peptide amphiphile micelles Soft Matter 2011, 7, 9572-9582 10.1039/c1sm05862b
18. Bisht, S.; Feldmann, G.; Koorstra, J.-B. M.; Mullendore, M.; Alvarez, H.; Karikari, C.; Rudek, M. A.; Lee, C. K.; Maitra, A.; Maitra, A. In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities Mol. Cancer Ther. 2008, 7, 3878-3888 10.1158/1535-7163.MCT-08-0476
19. Mlinar, L. B.; Chung, E. J.; Wonder, E. A.; Tirrell, M. Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles Biomaterials 2014, 35, 8678-8686 10.1016/j.biomaterials.2014.06.054
20. Chung, E. J.; Mlinar, L. B.; Nord, K.; Sugimoto, M. J.; Wonder, E.; Alenghat, F. J.; Fang, Y.; Tirrell, M. Monocyte-Targeting Supramolecular Micellar Assemblies: A Molecular Diagnostic Tool for Atherosclerosis Adv. Healthcare Mater. 2015, 4, 367-376 10.1002/adhm.201400336
21. Karmali, P. P.; Kotamraju, V. R.; Kastantin, M.; Black, M.; Missirlis, D.; Tirrell, M.; Ruoslahti, E. Targeting of albumin-embedded paclitaxel nanoparticles to tumors Nanomedicine 2009, 5, 73-82 10.1016/j.nano.2008.07.007
22. FDA. Drug Safety Communication: FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI). http://www.fda.gov/Drugs/DrugSafety/ucm455386.htm.
23. Beilvert, A.; Cormode, D. P.; Chaubet, F.; Briley-Saebo, K. C.; Mani, V.; Mulder, W. J. M.; Vucic, E.; Toussaint, J.-F.; Letourneur, D.; Fayad, Z. A. A tyrosine PEG-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque Magn. Reson. Med. 2009, 62, 1195-1201 10.1002/mrm.22103
24. Zhou, Z.; Lu, Z.-R. Gadolinium-Based Contrast Agents for MR Cancer Imaging Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2013, 5, 1-18 10.1002/wnan.1198
25. Langereis, S.; de Lussanet, Q. G.; van Genderen, M. H. P.; Backes, W. H.; Meijer, E. W. Multivalent Contrast Agents Based on Gadolinium-Diethylenetriaminepentaacetic Acid-Terminated Poly(propylene imine) Dendrimers for Magnetic Resonance Imaging Macromolecules 2004, 37, 3084-3091 10.1021/ma035983+
26. Grant, C. W. M.; Karlik, S.; Florio, E. A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA Magn. Reson. Med. 1989, 11, 236-243 10.1002/mrm.1910110211
27. Grant, C. W. M.; Barber, K. R.; Florio, E.; Karlik, S. A phospholipid spin label used as a liposome-associated MRI contrast agent Magn. Reson. Med. 1987, 5, 371-376 10.1002/mrm.1910050409
28. Hu, H. H.; Nayak, K. S. Change in the proton T1 of fat and water in mixture Magn. Reson. Med. 2010, 63, 494-501 10.1002/mrm.22205
29. Chan, L. W.; White, N. J.; Pun, S. H. Synthetic Strategies for Engineering Intravenous Hemostats Bioconjugate Chem. 2015, 26, 1224-1236 10.1021/acs.bioconjchem.5b00070
30. Reardon, C. A.; Getz, G. S. Mouse models of atherosclerosis Curr. Opin. Lipidol. 2001, 12, 167-173 10.1097/00041433-200104000-00010
31. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Baldelli Bombelli, F.; Dawson, K. A. Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles J. Am. Chem. Soc. 2011, 133, 2525-2534 10.1021/ja107583h
32. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 2009, 8, 543-557 10.1038/nmat2442
33. Deen, W. M.; Lazzara, M. J.; Myers, B. D. Structural determinants of glomerular permeability Am. J. Physiol. 2001, 281, F579-F596
34. Longmire, M.; Choyke, P. L.; Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats Nanomedicine 2008, 3, 703-717 10.2217/17435889.3.5.703
35. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Ipe, B. I.; Bawendi, M. G.; Frangioni, J. V. Renal clearance of quantum dots Nat. Biotechnol. 2007, 25, 1165-1170 10.1038/nbt1340
36. Malayeri, A. A.; Brooks, K. M.; Bryant, L. H.; Evers, R.; Kumar, P.; Reich, D. S.; Bluemke, D. A. National Institutes of Health perspective on reports of gadolinium deposition in the brain J. Am. Coll. Radiol. 2016, 13, 237-241 10.1016/j.jacr.2015.11.009
37. Chung, E. J.; Cheng, Y.; Morshed, R.; Nord, K.; Han, Y.; Wegscheid, M. L.; Auffinger, B.; Wainwright, D. A.; Lesniak, M. S.; Tirrell, M. V. Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma Biomaterials 2014, 35, 1249-1256 10.1016/j.biomaterials.2013.10.064
38. Wen, A. M.; Wang, Y.; Jiang, K.; Hsu, G. C.; Gao, H.; Lee, K. L.; Yang, A. C.; Yu, X.; Simon, D. I.; Steinmetz, N. F. Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging J. Mater. Chem. B 2015, 3, 6037-6045 10.1039/C5TB00879D
39. Whitman, S. C. A practical approach to using mice in atherosclerosis research Clin. Biochem. Rev. 2004, 25, 81-93
40. Briley-Saebo, K. C.; Cho, Y. S.; Shaw, P. X.; Ryu, S. K.; Mani, V.; Dickson, S.; Izadmehr, E.; Green, S.; Fayad, Z. A.; Tsimikas, S. Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes J. Am. Coll. Cardiol. 2011, 57, 337-347 10.1016/j.jacc.2010.09.023
41. van Tilborg, G. A. F.; Vucic, E.; Strijkers, G. J.; Cormode, D. P.; Mani, V.; Skajaa, T.; Reutelingsperger, C. P. M.; Fayad, Z. A.; Mulder, W. J. M.; Nicolay, K. Annexin A5-Functionalized Bimodal Nanoparticles for MRI and Fluorescence Imaging of Atherosclerotic Plaques Bioconjugate Chem. 2010, 21, 1794-1803 10.1021/bc100091q
42. Amirbekian, V.; Lipinski, M. J.; Briley-Saebo, K. C.; Amirbekian, S.; Aguinaldo, J. G. S.; Weinreb, D. B.; Vucic, E.; Frias, J. C.; Hyafil, F.; Mani, V.; Fisher, E. A.; Fayad, Z. A. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 961-966 10.1073/pnas.0606281104
43. te Boekhorst, B. C.; Bovens, S. M.; van de Kolk, C. W. A.; Cramer, M. J. M.; Doevendans, P. A. F. M.; ten Hove, M.; van der Weerd, L.; Poelmann, R.; Strijkers, G. J.; Pasterkamp, G.; van Echteld, C. J. A. The time window of MRI of murine atherosclerotic plaques after administration of CB2 receptor targeted micelles: inter-scan variability and relation between plaque signal intensity increase and gadolinium content of inversion recovery prepared versus non-prepared fast spin echo NMR Biomed. 2010, 23, 939-951 10.1002/nbm.1514